Press release
Insights on the Rheumatology Therapeutics Market to 2023 | Industry Statistics, Emerging Demands, Forecast to 2030 | Nintendo, Sony PlayStation Portable (PSP), Xbox Cloud Gaming
The global rheumatology therapeutics market is anticipated to grow at a CAGR of 3.2% during the forecast period (2023-2030). The growth of the rheumatology therapeutics market is primarily driven by the increased utilization of disease-modifying anti-rheumatic medicines (DMARDs) for targeted disease treatment. Recent steps in rheumatology have led to a diverse range of drug options available to rheumatologists, particularly for managing rheumatic joint disorders. The World Health Organization (WHO) reported that around 18 million individuals were living with rheumatoid arthritis globally in 2019. This condition predominantly affects women (70%) and those aged over 55 (55%).One such condition, Polymyalgia rheumatica, can severely impair daily activities due to its flares of painful symptoms across multiple body areas an approval by the FDA for a steroid-free treatment for polymyalgia rheumatica marks a significant step in treatment. For instance, in March 2023, for sarilumab (Kevzara), an interleukin (IL) 6 receptor antagonist, gained FDA approval for individuals with polymyalgia rheumatica who have either failed glucocorticoid treatment or cannot tolerate its tapering.
Often, patients with psoriatic arthritis are not able not suspect a connection between their psoriasis skin symptoms and the joint pain, swelling and stiffness, resulting in delayed diagnosis and treatment. For instance, in January 2022, AbbVie released FDA-approved SKYRIZI® (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), a systemic inflammatory disease that affects the skin and joints and impacts approximately 30% of patients with psoriasis. Ankylosing spondylitis (AS) is a chronic, inflammatory disease of the axial spine. Chronic back pain and progressive spinal stiffness are the most common features of this disease. For instance, in November 2021, Pfizer Inc. announced that the European Commission has approved XELJANZ® (tofacitinib) 5 mg twice daily for the treatment of adults with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy.
To Request a Sample of our Report on Rheumatology Therapeutics Market: https://www.omrglobal.com/request-sample/rheumatology-therapeutics-market
Market Coverage
The market number available for - 2023-2030
Base year- 2022
Forecast period- 2024-2030
Segment Covered-
By Drug Type
By Disease Indication
By Category
By Distribution Channel
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- includes Merck & Co., Inc., Novartis AG, Pfizer Inc. and others.
A full Report of Rheumatology Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/rheumatology-therapeutics-market
Rheumatology Therapeutics Market Report Segment
By Drug Type
Disease-modifying Anti-rheumatic Drugs
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Uric Acid Drugs
Others
By Disease Indication
Rheumatoid Arthritis
Osteoarthritis
Gout
Psoriatic Arthritis
Ankylosing Spondylitis
By Category
Prescription
Over-the-Counter (OTC)
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Rheumatology Therapeutics Market Report Segment by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East and Africa
Company Profiles
AbbVie Inc.
Amgen Inc.
AstraZeneca plc
Aurinia Pharmaceuticals Inc.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co.
Eli Lilly
Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
Janssen Pharmaceuticals, Inc.
Johnson & Johnson Private Ltd.
Regeneron Pharmaceuticals Inc.
Sanofi, Genentech, Inc.
Takeda Pharmaceutical Company Ltd.
UCB S.A.
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/rheumatology-therapeutics-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the Rheumatology Therapeutics Market to 2023 | Industry Statistics, Emerging Demands, Forecast to 2030 | Nintendo, Sony PlayStation Portable (PSP), Xbox Cloud Gaming here
News-ID: 3354739 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Rheumatology
Increasing Autoimmune Disease Prevalence Drives Rheumatology Therapeutics Market …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Rheumatology Therapeutics Market Size Growth Forecast: What to Expect by 2025?
The market for rheumatology therapeutics has seen robust growth in the recent past. The market size is expected to expand from $42.4 billion in 2024 to $44.61 billion in 2025, marking a compound annual growth rate (CAGR) of…
Rheumatology Therapeutics Market to Hit $59.1 Billion by 2030
◉ Global Rheumatology Therapeutics Market Set to Reach USD 59.1 Billion by 2030, Driven by Aging Population and Innovation
The global rheumatology therapeutics market is poised for steady growth, projected to reach nearly USD 59.1 billion by 2030, expanding at a CAGR of 2.7% from 2024 to 2030, according to Maximize Market Research. This growth is fueled by an aging global population, rising prevalence of rheumatic diseases, and continuous advancements in…
Rheumatology Therapeutics Market Insights, Status and Forecast to 2030
The latest research study released by AMA on the Rheumatology Therapeutics Market offers over 181 pages of analysis on business strategies employed by key and emerging industry players. It provides insights into current market developments, landscape, technologies, drivers, opportunities, market outlook, and status. The market study is segmented by key regions driving market growth. The Rheumatology Therapeutics study combines qualitative and quantitative market data, primarily collected and validated through primary…
Rheumatology Therapeutics Market 2023 Driving Factors Forecast Research 2029
Rheumatology Therapeutics market is anticipated to grow at a CAGR of 3.2% during the forecast period (2023-2030). Therapeutic drugs are used to slow down the progression of certain autoimmune rheumatic diseases such as rheumatic arthritis (RA). The increasing prevalence of RA globally has bolstered the launch of novel therapeutic agents and favorable refurbishment policies for high-cost treatment products are some of the factors driving the market growth. According to the…
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty
December 05-06, 2022 | Dubai, UAE
Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty
Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc.
Audience Profile:
· …
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology…